Michele Cimmino

Caserta, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-compliance.

Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-compliance.

Journal: Minerva cardiology and angiology

Published: November 13, 2025

Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study.

Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study.

Journal: International journal of cardiology

Published: October 21, 2025

Incidence, correlates, and outcomes of echocardiographic smoke-like effect after transcatheter edge-to-edge repair of mitral regurgitation with the MitraClip device.

Incidence, correlates, and outcomes of echocardiographic smoke-like effect after transcatheter edge-to-edge repair of mitral regurgitation with the MitraClip device.

Journal: The Journal of invasive cardiology

Published: May 22, 2025

Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study.

Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study.

Journal: Medicina (Kaunas, Lithuania)

Published: March 25, 2025

Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.

Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.

Journal: International journal of cardiology

Published: July 18, 2024

A 25-year-long journey into interventional cardiology: looking back, and rushing forward.

A 25-year-long journey into interventional cardiology: looking back, and rushing forward.

Journal: Minerva medica

Published: June 13, 2024

Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip.

Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip.

Journal: The American journal of cardiology

Published: June 01, 2024

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO-FAILS Study.

Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO-FAILS Study.

Journal: Journal of the American Heart Association

Published: May 14, 2024

Transcatheter mitral valve repair with MitraClip: comparison of NT, NTr, and XTr Devices.

Transcatheter mitral valve repair with MitraClip: comparison of NT, NTr, and XTr Devices.

Journal: The Journal of invasive cardiology

Published: April 10, 2024

Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry.

Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: November 15, 2023

Tirofiban prevents the effects of SARS-CoV-2 spike protein on macrophage activation and endothelial cell death.

Tirofiban prevents the effects of SARS-CoV-2 spike protein on macrophage activation and endothelial cell death.

Journal: Heliyon

Published: August 22, 2023

Outcomes of Transcatheter Aortic Valve Replacement in Patients With Severely Reduced Left Ventricular Systolic Function in the Low Systolic Function and Transcatheter Aortic Valve Implantation (LOSTAVI) International Registry.

Outcomes of Transcatheter Aortic Valve Replacement in Patients With Severely Reduced Left Ventricular Systolic Function in the Low Systolic Function and Transcatheter Aortic Valve Implantation (LOSTAVI) International Registry.

Journal: The American journal of cardiology

Published: May 03, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026